
Overview
I am a medical oncologist and researcher who specializes in treating patients with lung cancer and head and neck cancer. I’ve been at Duke for eight years. I first realized I wanted to become a doctor in graduate school, because it gave me the opportunity to practically apply scientific evidence to help others. What I love most about my job is working with our research and clinical staff to come up with new and hopeful therapies for patients. When a patient comes to see me, I look at their past and current medical history, review their lab tests, and then work with a team to figure out which treatment would work best for them. If a patient comes from far away, we try to make sure we can fit in visits with all the relevant specialists before they leave. Outside of work, I enjoy exercising with friends and spending time with my children at their various activities.
Dr. Ready is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
His clinical research consists of co-authoring 88 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Ready has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
University Of North Carolina At Chapel Hill
Trevor Hackman is an Otolaryngologist in Chapel Hill, North Carolina. Dr. Hackman is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Sialadenitis, Laryngectomy, and Gastrostomy. Dr. Hackman is currently accepting new patients.
University Of North Carolina At Chapel Hill
Wendell Yarbrough is an Otolaryngologist in Chapel Hill, North Carolina. Dr. Yarbrough is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Frey's Syndrome, Salivary Gland Tumors, Laryngectomy, and Glossectomy. Dr. Yarbrough is currently accepting new patients.
Mark Weissler is an Otolaryngologist in Chapel Hill, North Carolina. Dr. Weissler is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Thyroidectomy, and Laryngectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Ready isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Ready isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Ready isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Ready isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Laryngeal CancerDr. Ready isDistinguished. Learn about Laryngeal Cancer.
- Lung AdenocarcinomaDr. Ready isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Ready isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Epithelial-Myoepithelial Carcinoma
- GliomaDr. Ready isAdvanced. Learn about Glioma.
- MesotheliomaDr. Ready isAdvanced. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Ready isAdvanced. Learn about Metastatic Pleural Tumor.
- Nasopharyngeal CarcinomaDr. Ready isAdvanced. Learn about Nasopharyngeal Carcinoma.
- Polymorphous Low Grade Adenocarcinoma
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Ready isExperienced. Learn about Adenoid Cystic Carcinoma.
- Anaplastic Thyroid CancerDr. Ready isExperienced. Learn about Anaplastic Thyroid Cancer.
- Bone TumorDr. Ready isExperienced. Learn about Bone Tumor.
- Breast CancerDr. Ready isExperienced. Learn about Breast Cancer.
- Ear CancerDr. Ready isExperienced. Learn about Ear Cancer.
